Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5941 AL 5955

Positron Emission Tomography and Single-Photon Emission Computed Tomography in Neurology

Miletich RS.

Continuum (Minneap Minn). 2016 Oct;22(5, Neuroimaging):1636-1654. doi: 10.1212/CON.0000000000000389.

Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases

Van der Schyf CJ.

Drug Dev Res. 2016 Dec;77(8):458-468. doi: 10.1002/ddr.21368. Epub 2016 Nov 4.

Aging of cerebral white matter

Liu H, Yang Y, Xia Y, Zhu W, Leak RK, Wei Z, Wang J, Hu X.

Ageing Res Rev. 2017 Mar;34:64-76. doi: 10.1016/j.arr.2016.11.006. Epub 2016 Nov 16.

Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis

Lyoo CH, Cho H, Choi JY, Hwang MS, Hong SK, Kim YJ, Ryu YH, Lee MS.

J Alzheimers Dis. 2016;51(3):671-5. doi: 10.3233/JAD-151052.

The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease

Clark LF, Kodadek T.

ACS Chem Neurosci. 2016 May 18;7(5):520-7. doi: 10.1021/acschemneuro.6b00042. Epub 2016 Apr 14.

Palmitoylation in Alzheimer's disease and other neurodegenerative diseases

Cho E, Park M.

Pharmacol Res. 2016 Sep;111:133-151. doi: 10.1016/j.phrs.2016.06.008. Epub 2016 Jun 9.

Eye movements in neurodegenerative diseases

MacAskill MR, Anderson TJ.

Curr Opin Neurol. 2016 Feb;29(1):61-8. doi: 10.1097/WCO.0000000000000274.

The rationale for deep brain stimulation in Alzheimer's disease

Mirzadeh Z, Bari A, Lozano AM.

J Neural Transm (Vienna). 2016 Jul;123(7):775-783. doi: 10.1007/s00702-015-1462-9. Epub 2015 Oct 6.

Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis

Viola KL, Klein WL.

Acta Neuropathol. 2015 Feb;129(2):183-206. doi: 10.1007/s00401-015-1386-3. Epub 2015 Jan 22.

Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17

Kasuga K, Kikuchi M, Tokutake T, Nakaya A, Tezuka T, Tsukie T, Hara N, Miyashita A, Kuwano R, Ikeuchi T.

J Hum Genet. 2015 May;60(5):281-3. doi: 10.1038/jhg.2015.15. Epub 2015 Feb 19.

From Neurodegeneration to Brain Health: An Integrated Approach

Petersen RB, Lissemore FM, Appleby B, Aggarwal N, Boyatzis R, Casadesus G, Cummings J, Jack A, Perry G, Safar J, Sajatovic M, Surewicz WK, Wang Y, Whitehouse P, Lerner A.

J Alzheimers Dis. 2015;46(1):271-83. doi: 10.3233/JAD-150043.

[Differential diagnosis of dementia with lewy bodies]

Orimo S.

Brain Nerve. 2015 Apr;67(4):413-25. doi: 10.11477/mf.1416200157.

Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders

Wang ZY, Han ZM, Liu QF, Tang W, Ye K, Yao YY.

Int Psychogeriatr. 2015 Sep;27(9):1429-38. doi: 10.1017/S1041610215000447. Epub 2015 Apr 8.

PET imaging in neurology: Alzheimer's and Parkinson's diseases

Sarikaya I.

Nucl Med Commun. 2015 Aug;36(8):775-81. doi: 10.1097/MNM.0000000000000320.

Olfaction deterioration in cognitive disorders in the elderly

Ottaviano G, Frasson G, Nardello E, Martini A.

Aging Clin Exp Res. 2016 Feb;28(1):37-45. doi: 10.1007/s40520-015-0380-x. Epub 2015 May 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias